Enzo Biochem

Enzo Biochem Book Value per Share

Delisted

The Book Value per Share of Enzo Biochem (ENZ) as of Oct 8, 2026 is 0.57 USD. In the previous year, Book Value per Share was 0.49 USD — a change of 14.40% (higher).

Book Value per Share

0.57USD

YoY

14.40%

Last updated:

Book Value per Share of Enzo Biochem is 2023 0.57 USD. Book Value per Share of Enzo Biochem was 2022 0.49 USD. It decreases by 14.40% higher compared to the previous year.

The Enzo Biochem Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2015
0.31 USD
Jan 1, 2016
0.65 USD
Jan 1, 2017
0.64 USD
Jan 1, 2018
0.58 USD
Jan 1, 2019
0.62 USD
Jan 1, 2020
0.42 USD
Jan 1, 2021
0.49 USD
Jan 1, 2023
0.57 USD
The Enzo Biochem Book Value per Share history
YEARBook Value per ShareYoY
0.57USD+14.40%
0.49USD+17.44%
0.42USD-32.09%
0.62USD+6.04%
0.58USD-8.77%
0.64USD-0.78%
0.65USD+110.33%
0.31USD+15.14%
0.27USD—
Access this data via the Eulerpool API

Enzo Biochem Stock analysis

What does Enzo Biochem do? Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzo Biochem stock

Book Value per Share of Enzo Biochem is 0.57 USD in 2023.

Book Value per Share of Enzo Biochem changed from 0.49 USD to 0.57 USD, representing a 14.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Enzo Biochem since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

Balance Sheet — Enzo Biochem

All Key Metrics — Enzo Biochem